Japan’s medical device market is highly dependent on imports, especially sophisticated products such as pacemakers and surgical robotic systems.
From being a market with long approval times, new regulatory procedures have resulted in shorter approval times in recent years. According to Nikkei Asia, the Japanese government is now planning to cut the need for regulatory approval to update AI software used as a medical device or SaMD.
This development will facilitate for EU companies considering entering the Japanese market. The increasing need for automation in the Japanese healthcare industry, could offer EU companies market opportunities in various segments including robot surgery.
The webinar targets EU small- and medium-sized companies seeking to find opportunities in the Japanese medical device market.
In 40 minutes from your desk, discover:
Registration deadline: 14 March 2022
Speaker: Maths Lundin, founder of Sweden Japan Consulting (SJC), has more than 35 years of experience working in Japan in sectors such as home appliances, system kitchens and nano technology. He is now working as consultant helping European companies set up business in Japan
Moderator: Pauline Laloux, Business Support Coordinator, EU-Japan Centre
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office